CLINICAL_TRIALS
trial_result
· 2020-03-18
Clinical Trial Update: Subject Satisfaction With AbobutulinumtoxinA Treatment [Phase 4]
Summary
A Phase 4 clinical trial assessing patient satisfaction with AbobutulinumtoxinA for glabellar frown lines has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines | Phase 4 | Status: COMPLETED | Results posted: 2020-03-18